BioSpace News Archive

Pharm Country

Pfizer Adds Second Checkpoint Inhibitor to its Pipeline with $200 Million Stake in CStone

Pfizer invested $200 million into the company for a nearly 10% stake to support the development of a checkpoint inhibitor aimed at the oncology market in China.

September 30, 2020
·
2 min read
·
Alex Keown
Business

New Collab Boosts Serum Institute of India’s COVID-19 Vaccine Production by 100 Million Doses

The Serum Institute of India (SII) has agreed to produce and deliver up to an additional 100 million doses of an approved COVID-19 vaccine for citizens of India and neighboring low- and middle-income countries as part of a collaboration with Gavi and the Bill & Melinda Gates Foundation.

September 30, 2020
·
3 min read
·
Brandon May
CRISPR Technology Edges Closer to Commercial Use

While CRISPR has been used as a research tool for the most part, the technology is moving toward commercial applications.

September 30, 2020
·
7 min read
·
Joseph Constance
FDA

Judge Sides with FDA, Jacobus Pharma in Fight Over LEMS Treatment Approval

Catalyst Pharmaceuticals is reeling this morning after a federal judge dismissed the company’s lawsuit against the U.S. Food and Drug Administration regarding the approval of a rival drug for a rare autoimmune disease from New Jersey-based Jacobus Pharmaceutical.

September 30, 2020
·
2 min read
·
Alex Keown
Drug Development

Study: Moderna’s COVID-19 Vaccine Appears to Be Safe and Effective in Older Adults

Moderna published second interim analysis of its open-label Phase I trial of its COVID-19 vaccine, mRNA-1273, in The New England Journal of Medicine.

September 30, 2020
·
3 min read
·
Mark Terry
Deals

Blank Check Company Vesper Healthcare Prices $400 Million IPO at $10 Per Unit

The special purpose acquisition company, which has listed the units and is beginning to trade on the Nasdaq Capital Market, expects the proposed deal to command a market value of close to $500 million.

September 30, 2020
·
2 min read
·
Brandon May
Drug Development

Early Data Shows Regeneron’s COVID-19 Antibody Cocktail Helps Patients Recover Faster

Although still preliminary, Regeneron Pharmaceuticals announced early data from its Phase I/II/III trial of its antibody cocktail, REGN-COV2, against COVID-19.

September 30, 2020
·
4 min read
·
Mark Terry
BioSpace Global Roundup, Oct. 1

Biopharma and life sciences companies from across the globe provide updates on their pipelines and business practices.

September 30, 2020
·
8 min read
·
Alex Keown
Pharm Country

Flame Bioscience to Ignite Pipeline with $100M Common Stock Financing

Proceeds from common stock financing will be used to progress clinical trials for inflammation-driven lung cancer and inflammatory diseases.

September 30, 2020
·
2 min read
·
Kate Goodwin
Pharm Country

University Malaya Specialist Centre (UMSC) Neurosurgeons Turn to Vuzix Smart Glasses for Patient Care in the ICU During COVID-19 Pandemic

Vuzix® Corporation (NASDAQ: VUZI), (“Vuzix” or, the “Company”), a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, today is announcing that the Company’s M400 Smart Glasses are being used by University Malaya Specialist Centre (USMC) in Malaysia

September 30, 2020
·
5 min read